<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02700581</url>
  </required_header>
  <id_info>
    <org_study_id>KUH000000 TBD</org_study_id>
    <nct_id>NCT02700581</nct_id>
  </id_info>
  <brief_title>Impact of Positive End-expiratory Pressure on Hepatic Venous Flow</brief_title>
  <official_title>Impact of Moderate Positive End-expiratory Pressure on Hepatic Venous Flow in Patients Undergoing Cardiac Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Konkuk University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Konkuk University Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the difference in the impact of moderate positive
      end-expiratory pressure (PEEP) on hepatic venous flow Doppler in patients undergoing cardiac
      surgery: conventional versus protective ventilation strategy The possible changes in forward
      and backward flows (Doppler profiles) of hepatic venous flow at different degrees of PEEP in
      conventional and protective ventilation strategies are analyzed by using intraoperative
      transesophageal echocardiography (TEE) in patients undergoing cardiac surgery .
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Following data would be determined after 5 min-exposure volume controlled ventilation
      employing tidal volume of 10 ml/kg and 6 ml/kg with low PEEP (with 2 mmHg) and moderate PEEP
      (7 mmHg) during remifentanil-based anesthesia (1.0 mcg/kg/min) for cardiac surgery (n=12)

        1. sum of forward hepatic venous flow

        2. sum of backward hepatic venous flow

        3. peak velocity of diastolic hepatic venous flow

        4. lung compliance

        5. peak airway pressure

        6. mean airway pressure

        7. other pressure derived hemodynamic parameters:heart rate; systolic, diastolic, and mean
           blood pressures; systolic, diastolic, and mean pulmonary artery pressures; central
           venous pressure (CVP), pulmonary capillary
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>March 2016</start_date>
  <completion_date type="Anticipated">May 2016</completion_date>
  <primary_completion_date type="Anticipated">April 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>forward hepatic venous flow</measure>
    <time_frame>3 min after intervention</time_frame>
    <description>Hepatic venous flow Doppler, cm/sec, by transesophageal echocardiography</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>reversed hepatic venous flow</measure>
    <time_frame>3 min after intervention</time_frame>
    <description>Reversed hepatic venous flow Doppler, cm/sec, by transesophageal echocardiography</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">15</enrollment>
  <condition>Valvular Heart Disease</condition>
  <arm_group>
    <arm_group_label>low PEEP conventional ventilation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>PEEP 2 mmHg tidal volume 10ml/kg</description>
  </arm_group>
  <arm_group>
    <arm_group_label>moderate PEEP conventional ventilation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>PEEP 7 mmHg tidal volume 10ml/kg</description>
  </arm_group>
  <arm_group>
    <arm_group_label>low PEEP protective ventilation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>PEEP 2 mmHg with tidal volume 6 ml/kg</description>
  </arm_group>
  <arm_group>
    <arm_group_label>moderate PEEP protective ventilation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>PEEP 7 mmHg tidal volume 6ml/kg</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>low PEEP conventional ventilation</intervention_name>
    <arm_group_label>low PEEP conventional ventilation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>moderate PEEP conventional ventilation</intervention_name>
    <arm_group_label>moderate PEEP conventional ventilation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>low PEEP protective ventilation</intervention_name>
    <arm_group_label>low PEEP protective ventilation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>moderate PEEP protective ventilation</intervention_name>
    <arm_group_label>moderate PEEP protective ventilation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients undergoing cardiac surgery

          -  Patients provide written informed consents

        Exclusion Criteria:

          -  Re-do or tri-do surgery

          -  Patients with active infection

          -  Patients with endocrine disease

          -  Patients ischemic heart disease

          -  patients with tricuspid valve regurgitation greater than mild degree
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Tae-Yop Kim, MD, PhD</last_name>
    <phone>+82222926942</phone>
    <email>taeyop@gmail.com</email>
  </overall_contact>
  <verification_date>March 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 23, 2016</study_first_submitted>
  <study_first_submitted_qc>March 1, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 7, 2016</study_first_posted>
  <last_update_submitted>March 1, 2016</last_update_submitted>
  <last_update_submitted_qc>March 1, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 7, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Konkuk University Medical Center</investigator_affiliation>
    <investigator_full_name>Tae-Yop Kim, MD PhD</investigator_full_name>
    <investigator_title>Professor of Anesthesiology</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Heart Valve Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

